| Company Name: |
Pharmacodia (Beijing) Co.,Ltd
|
| Tel: |
+86-400-851-9921 |
| Email: |
sales@pharmacodia.com |
| Products Intro: |
Product Name:Everolimus IMP
Purity:95% Package:50mg;100mg
|
|
| | EveroliMus iMpurity Basic information |
| Product Name: | EveroliMus iMpurity | | Synonyms: | Everolimus IMP;(Everolimus-13C2-d4;Everolimus Impurity 23(Everolimus-13C2-d4);Everolimus Impurity 23;Everolimus-13C2,D4 (~90%)
DISCONTINUED. Please see E945402.;Everolimus-13C2,d4 (Everolimus Impurity) | | CAS: | 1661009-29-5 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![EveroliMus iMpurity Structure]() |
| | EveroliMus iMpurity Chemical Properties |
| | EveroliMus iMpurity Usage And Synthesis |
| Uses | Everolimus-13C2,D4 is used in the evaluation of LC-MS method for everolimus preclinical determination in brain by using [13C2D4]RAD001 internal standard. An Isotopically labelled analog of Everolimus (E945400), a derivative of Rapamycin, that also inhibits cytokine-mediated lymphocyte proliferation. |
| | EveroliMus iMpurity Preparation Products And Raw materials |
|